scispace - formally typeset
Journal ArticleDOI

Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy

Reads0
Chats0
TLDR
carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections, indicating the importance of their concurrent evaluation, especially during chronic studies.
Abstract
The competitive relationship between d-amphetamine induced stereotypy and locomotor activity indicates the importance of their concurrent evaluation, especially during chronic studies. Repeated injection of 0.5, 1.0, 2.5, 5.0, or 7.5 mg/kg d-amphetamine for 36 successive days, in rats continuously exposed to the experimental chambers, produced a progressive augmentation in stereotypy and/or locomotion (depending on dose) during the 3–4 hr interval following injections (post-injection phase). In contrast, dark phase locomotor activity (8–20 hr after each daily injection) was maximally reduced (30–40% of controls) after the first injection of either 5.0 or 7.5 mg/kg d-amphetamine and gradually declined to this level with repeated injection of 1.0 and 2.5 mg/kg. Carry-over of both the post-injection augmentation and dark phase reduction of locomotion was revealed during amphetamine retest 8 days following discontinuation of daily d-amphetamine injections. Possible mechanisms underlying these behavioral alterations are discussed.

read more

Citations
More filters
Journal ArticleDOI

Shift from inhibition to excitation in the neostriatum but not in the nucleus accumbens following long-term amphethamine

TL;DR: Electrophysiological and neurochemical changes are discussed in relation to the known involvement of these sites in the dose-dependent behavioral alterations that accompany repeated amphetamine injections in rats pretreated with these doses.
Journal ArticleDOI

Behavioral sensitization to ethanol results in cross-sensitization to MK-801 but not to NMDA administered intra-accumbens.

TL;DR: The goal of the present study was to analyze the involvement of accumbal glutamate NMDA receptors in the locomotion behavioral response to an NMDA agonist or to anNMDA antagonist in mice previously treated with ethanol, and observe cross-sensitization between repeated ethanol treatment and the intra-NAc administration of MK-801.
Journal ArticleDOI

Hippocampal glucocorticoid receptor mRNA is up-regulated by acute and down-regulated by chronic amphetamine treatment

TL;DR: A role for hippocampal GR mRNA in the development of behavioral sensitization is supported by the effects of five daily injections of amphetamine on GR mRNA of adult Sprague-Dawley rats.
Journal ArticleDOI

Reversal of amphetamine-induced circling preference in trained circling rats

TL;DR: Investigating the effect of training on amphetamine-induced behavioral and biochemical asymmetries in male Sprague-Dawley rats found intrinsic striatal lateralization is not resistant to behavioral modification and both the behavioral andochemical asymmetry can be reversed by circling training.
Journal ArticleDOI

The effect of chronic administration of d‐amphetamine on regional changes in catecholamines in the rat brain

TL;DR: Most of the brain areas showed a decrease in the dopamine concentration apart from the olfactory lobes which showed an increase and the midbrain and hippocampus which were largely unchanged, suggesting that the turnover of dopamine was decreased.
References
More filters
Journal Article

Antiamphetamine effects following inhibition of tyrosine hydroxylase

TL;DR: The antiamphetamine effects of α-MT and other tyrosine hydroxylase inhibitors suggest that a critical level of norepinephrine at the receptor is required for amphetamine to exert its customary effects.
Journal ArticleDOI

Role of Catecholamines in the Amphetamine Excitatory Response

A. Randrup, +1 more
- 30 Jul 1966 - 
TL;DR: The advent of α-methyl para-tyrosine3 (α-MPT), which inhibits the in vivo synthesis of 3,4-dihydroxyphenylalanine (DOPA)—the physiological precursor of the catecholamines—offers a new way of investigating this problem.
Related Papers (5)